Hypothalmupar
Active substance: AMERICAN GINSENG, GINKGO, CENTELLA ASIATICA WHOLE, SUS SCROFA CEREBRUM, SUS SCROFA PITUITARY GLAND, SUS SCROFA HYPOTHALAMUS, PHOSPHORUS, SILICON DIOXIDE
LIQUID · AMERICAN GINSENG 3 [hp_X]/mL, GINKGO 3 [hp_X]/mL, CENTELLA ASIATICA WHOLE 3 [hp_X]/mL, SUS SCROFA CEREBRUM 8 [hp_X]/mL, SUS SCROFA PITUITARY GLAND 8 [hp_X]/mL, SUS SCROFA HYPOTHALAMUS 12 [hp_X]/mL, PHOSPHORUS 12 [hp_X]/mL, SILICON DIOXIDE 12 [hp_X]/mL
United StatesActive
Marketing holder: Energique, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- AMERICAN GINSENG · 3 [hp_X]/mL
- GINKGO · 3 [hp_X]/mL
- CENTELLA ASIATICA WHOLE · 3 [hp_X]/mL
- SUS SCROFA CEREBRUM · 8 [hp_X]/mL
- SUS SCROFA PITUITARY GLAND · 8 [hp_X]/mL
- SUS SCROFA HYPOTHALAMUS · 12 [hp_X]/mL
- PHOSPHORUS · 12 [hp_X]/mL
- SILICON DIOXIDE · 12 [hp_X]/mL
Registration
- Registration number
- 44911-0473
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 44911-0473 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 44911-0473 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 44911-0473 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 44911-0473 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 44911-0473 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 44911-0473 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 44911-0473 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 44911-0473 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 44911-0473 · Verified 2026-10-09 · open in source
- ingredients.7 · openFDA NDC · 44911-0473 · Verified 2026-10-09 · open in source